Viewing Study NCT06531395


Ignite Creation Date: 2025-12-24 @ 1:19 PM
Ignite Modification Date: 2026-01-11 @ 6:01 AM
Study NCT ID: NCT06531395
Status: TERMINATED
Last Update Posted: 2025-05-21
First Post: 2024-07-25
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Evaluate the Efficacy and Safety of Abiprubart in Participants With Sjögren's Disease
Sponsor: Kiniksa Pharmaceuticals International, plc
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module